Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus
Clin Endocrinol (Oxf)
.
2024 Nov;101(5):443-445.
doi: 10.1111/cen.14819.
Epub 2022 Oct 14.
Authors
Hiroshi Arima
1
,
Timothy Cheetham
2
3
,
Mirjam Christ-Crain
4
,
Deborah Cooper
5
,
Juliana Drummond
6
,
Mark Gurnell
7
,
Miles Levy
8
,
Ann McCormack
9
10
11
,
John Newell-Price
12
,
Joseph G Verbalis
13
,
John Wass
14
Affiliations
1
Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan.
2
Newcastle University, Newcastle upon Tyne, UK.
3
Great North Children s Hospital (GNCH), Newcastle upon Tyne, UK.
4
Department of Endocrinology, University Hospital and University of Basel, Basel, Switzerland.
5
Pituitary Foundation, Bristol, UK.
6
Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
7
Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
8
Department of Endocrinology, University Hospitals of Leicester NHS Trust, Leicester, UK.
9
Department of Endocrinology, St Vincent's Hospital, Sydney, NSW, Australia.
10
Garvan Institute of Medical Research, Sydney, NSW, Australia.
11
St Vincent s Clinical School, University of New South Wales, Sydney, NSW, Australia.
12
Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK.
13
Georgetown-Howard Universities Center for Clinical and Translational Science, Georgetown University, Washington, DC, USA.
14
Department of Endocrinology, University of Oxford, Churchill Hospital, Oxford, UK.
PMID:
36030512
DOI:
10.1111/cen.14819
No abstract available
Publication types
Letter